Showing results (401-410 of 13,200) with videos related to

Sort By:
Pageof 1,320
Diabetes Care|June 28, 2006
Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)Robert H Knopp, Michael d'Emden, Johan G Smilde, et al.
Diabetes Care|June 28, 2006
Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36Philip M Clarke, Judit Simon, Carole A Cull, et al.
Diabetes Care|June 28, 2006
IGF-binding protein-1 levels are related to insulin-mediated glucose disposal and are a potential serum marker of insulin resistanceBetty A Maddux, Adelene Chan, Elena A De Filippis, et al.
Diabetes Care|June 28, 2006
Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications TrialNigishi Hotta, Yasuo Akanuma, Ryuzo Kawamori, et al.
Diabetes Care|June 28, 2006
Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetesHoward N Hodis, Wendy J Mack, Ling Zheng, et al.
Diabetes Care|June 28, 2006
Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?Richard J MacIsaac, Sianna Panagiotopoulos, Karen J McNeil, et al.
Diabetes Care|June 28, 2006
Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoterPeter E H Schwarz, Gordon W Towers, Sabine Fischer, et al.
Diabetes Care|June 28, 2006
A systematic review of interventions to improve diabetes care in socially disadvantaged populationsRichard H Glazier, Jana Bajcar, Natalie R Kennie, et al.
Diabetes Care|June 1, 1991
Drug treatment of hypertension in patients with diabetes mellitusP P Stein, H R Black
Diabetes Care|May 9, 2007
Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the EURODIAB Prospective Complications StudySara Giunti, Graziella Bruno, Emma Lillaz, et al.
Pageof 1,320